ranimustine has been researched along with Lymphoma, Non-Hodgkin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harigae, H; Hirokawa, M; Ishida, Y; Ishizawa, K; Ito, J; Kameoka, Y; Kato, Y; Murai, K; Noji, H; Sasaki, O; Sawada, K; Shichishima, T; Tajima, K; Takahashi, N | 1 |
| Aoyama, Y; Hino, M; Kamitani, T; Kishida, T; Koh, KR; Mugitani, A; Nakamae, H; Ohta, K; Ota, T; Sannomiya, Y; Takubo, T; Tatsumi, N; Yamane, T | 1 |
| Oguro, M; Sakai, C; Takagi, T | 1 |
| Kawano, Y; Koyama, T; Kuroda, Y; Ninomiya, T; Shimokawa, T; Takaue, Y; Watanabe, T | 1 |
2 trial(s) available for ranimustine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous | 2012 |
[High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Vincristine | 2000 |
2 other study(ies) available for ranimustine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
[BH-AC.nitrosourea-therapy for refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Recurrence | 1992 |
[Interstitial pneumonitis following high-dose MCNU].
Topics: Antineoplastic Agents; Child; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Nitrosourea Compounds; Pulmonary Diffusing Capacity; Pulmonary Fibrosis | 1989 |